Aniracetam Capsules
Function and Efficacy
This product is a cyclized derivative of γ-aminobutyric acid (GABA). It has the ability to resist hypoxia in the cortex and protect learning and memory loss caused by various chemicals, including hypercapnia, scopolamine or electric shock, but it has no sedative or excitatory effect, nor vasodilation effect. Animal experiments have also shown that this product works partly by protecting the function of cholinergic neurons, which can protect the brain from the decrease of acetylcholine and memory loss caused by scopolamine, and can also stimulate the reabsorption of choline by the presynaptic membrane and accelerate the synthesis of acetylcholine.
Ingredients
Aniracetam. Chemical name: 1-(4-methoxybenzoyl)-2-pyrrolidone.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| AniracetamIngredients |
This product is a cyclized derivative of γ-aminobutyric acid (GABA), which has the ability to resist hypoxia in the cortex and protect learning and memory loss caused by various chemicals, including hypercapnia, scopolamine or electric shock, but it has no sedative or excitatory effect, nor vasodilation effect. It works partly by protecting the function of cholinergic neurons, which can protect the brain from the decrease of acetylcholine and memory loss caused by scopolamine, and can also stimulate the reabsorption of choline by the presynaptic membrane and accelerate the synthesis of acetylcholine. More |
72432-10-1 | 11 |
Appearance
This product is a capsule, and the contents are white to off-white powder.
Indication
1. Vascular dementia and Alzheimer's disease with mild to moderate learning, memory and cognitive dysfunction. 2. Mild to moderate cognitive and behavioral disorders after stroke. 3. Benign memory impairment in middle-aged and elderly people.
Usage and Dosage
Oral administration, 0.2g (2 tablets) at a time, 3 times a day, for 1 to 2 months, or as directed by a doctor. The dosage and course of treatment may be increased or decreased as appropriate depending on the condition and the reaction after taking the medicine.
Adverse Reactions
Adverse reactions may include dry mouth, loss of appetite, constipation, dizziness, and drowsiness, which disappear after stopping the drug. Occasionally, there are reports of excitement, restlessness, and systemic rash.
Precautions
Patients who are allergic to this product or cannot tolerate other pyrrolidone drugs should avoid using it.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: The usual dosage is: for people over 70 years old, 0.1g (1 capsule) each time, 3 times a day; for people under 70 years old, 0.2g (2 capsules) each time, 3 times a day.
Drug Interactions
Not yet clear.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
0.1g
Validity Period
24 months
Manufacturer
Wuxi Kaifu Pharmaceutical Co., Ltd.
-
Founded in:
2001-02-15 -
Address:
No. 12, Xiaguang Road, Mashan, Binhu District, Wuxi City (Inside Mashan Town Industrial Park) -
Tax NO.:
913202117265560329 -
Registered Funds:
70 million yuan -
Website:
-
Email: